Internal Medicine, Nephrology · Union, NJ
NPI
1124081336
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
440 Chestnut St
Union, NJ, 07083
Phone (908) 686-9330
Groups this clinician bills Medicare through
Medicare paid, 2024
$111K
1,109 services
Medicare patients, 2024
225
Average age 74
Drug cost, 2024
$4.6M
9,051 prescriptions
Company payments, 2025
$18K
From 32 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeffrey N Feldman was code 99215 (office e&m - established), 459 times for 165 patients. In total Jeffrey N Feldman billed 1,109 services in 20 codes, and Medicare paid $111K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-03-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 459 | 165 | $141.33 | $65K |
| 99214 Office E&M - Established | Office | 170 | 90 | $95.70 | $16K |
| 99233 Hospital E&M - Subsequent | Facility | 118 | 25 | $97.39 | $11K |
| 99232 Hospital E&M - Subsequent | Facility | 85 | 18 | $65.78 | $5,591 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 81 | 72 | $13.81 | $1,118 |
| 99205 Office E&M - New | Office | 28 | 28 | $155.12 | $4,343 |
| 99222 Hospital E&M - Initial | Facility | 26 | 20 | $110.08 | $2,862 |
| 83037 Blood Count | Office | 19 | 14 | $9.52 | $181 |
| 99204 Office E&M - New | Office | 14 | 14 | $124.40 | $1,742 |
By year: 2022 $133K for 4,191 services; 2023 $125K for 1,301 services; 2024 $111K for 1,109 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83037 Blood Count | 19 | 14 | $9.52 | $181 |
Medicare prescription drug claims, 2024
In 2024, the drug Jeffrey N Feldman prescribed most often to Medicare patients was Kerendia (Finerenone), with 782 prescriptions and refills. In total Jeffrey N Feldman wrote 9,051 Medicare prescriptions that cost $4.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Kerendia Finerenone | 782 | 1,709 | 196 | $1.1M |
| Atorvastatin Calcium Generic | 626 | 1,638 | 196 | $5,787 |
| Jardiance Empagliflozin | 487 | 1,053 | 134 | $608K |
| Ozempic Semaglutide | 423 | 640 | 93 | $616K |
| Carvedilol Generic | 344 | 790 | 97 | $3,337 |
| Nifedipine Er Nifedipine | 290 | 668 | 78 | $8,353 |
| Mounjaro Tirzepatide | 287 | 418 | 46 | $444K |
| Farxiga Dapagliflozin Propanediol | 210 | 446 | 52 | $247K |
| Amlodipine Besylate Generic | 203 | 474 | 60 | $1,123 |
| Rosuvastatin Calcium Generic | 182 | 511 | 59 | $3,170 |
| Ezetimibe Generic | 178 | 448 | 54 | $3,067 |
| Olmesartan Medoxomil Generic | 174 | 435 | 53 | $4,070 |
| Rayaldee Calcifediol | 173 | 197 | 26 | $274K |
| Pioglitazone Hcl Generic | 135 | 363 | 36 | $1,712 |
| Famotidine Generic | 130 | 289 | 39 | $2,679 |
Brand drugs: 3,537 claims; generic drugs: 5,445 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeffrey N Feldman $18K ($18K in general payments such as food, travel and fees) from 32 companies. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $8,343.
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 27 | $8,343 |
| Lilly USA, LLC LLY | 16 | $5,608 |
| Novo Nordisk Inc NVO | 34 | $677 |
| Amgen Inc. AMGN | 17 | $506 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 16 | $502 |
| Corcept Therapeutics CORT | 14 | $307 |
| Novartis Pharmaceuticals Corporation NVS | 11 | $281 |
| Scpharmaceuticals Inc. SCPH | 9 | $245 |
| AstraZeneca Pharmaceuticals LP AZN | 12 | $194 |
| Vifor Pharma, Inc. | 12 | $185 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.